These results indicate that ST3 and Neu3 levels or ratios in peripheral blood monocytes and PMN cells, may be used to differentiate between patients with and without two lupus symptoms (proteinuria and arthritis) and between greater and lesser disease activity (in SLEDAI scores). This evidence concerns the gene NEU3 and Arthritis.